[A2k] Maastricht Workshop on Medical innovation prizes as a mechanism to promote innovation and access, Jan 28-29, 2007

[Malini Aisola]

The following is the current agenda for a workshop in Maastricht, the
Netherlands, on January 28-29, 2007, on the topic of medical innovation
prizes.  The workshop is being organized by UNU-MERIT and KEI.


Malini

Knowledge Ecology International
1621 Connecticut Ave., NW, Washington, DC 20009 USA
Tel.:  +1.202.332.2670 Fax: +1.202.332.2673
---------------------------------------------------------------------------=
----------------------

Medical innovation prizes as a mechanism to promote innovation and access
Draft agenda, 19 December 2008


Monday, Jan 28

Welcome

    Konrad Osterwalder, Rector, United Nations University
    James Love, KEI

Panel 1  Overview, prizes to stimulate innovation

    Chair:  Kalipso Chalkidou, UK NICE

    William Fisher, Harvard Law School, prizes for medical innovation
    Steve Merrill, NAS, innovation prizes in other fields
    Thomas C. Erren, Institute and Policlinic for Occupational and
Social Medicine, School of Medicine and Dentistry, University of
Cologne, Lindenthal, Germany

Break

Panel 2  Prizes, the U.S. and European Context

    Chair:  Suerie Moon, Harvard, KSG

    Dwayne Spradlin, CEO, Innocentive, Prizes for Research tools and
Basic Medical Research
    Nicole Szlezak, Chief Scientific Officer, Prize for Life
    David Reynolds, Senator Sanders Office, S.2210, the Medical
Innovation Prize
    Joan Rovira, Autonomous University of Barcelona, Spain


Lunch

Panel 3  Prizes for developing countries

    Chair: Thiru Balasubramaniam, KEI

    Pierre Chirac, MSF, prize for TB low-cost point of care rapid
diagnostic test
    Aidan Hollis, University of Calgary, a voluntary prize mechanism

Break

Panel 4  Issues in Prize Design

    Chair: Roxanna Bonnell, OSI

    John Erickson (TBC), CEO Sequoia Pharmaceuticals, a system of prizes
that rewards product development in stages
    Sisule Musungu, Yale, Prizes as an alternative to marketing
monopolies as an implementation of TRIPS obligations


Panel 5  Views of Developing Countries

       Chair: Spring Gombe, KEI

       Dilip Shah, Indian Generics Association
       Ahmed Latif, ICTSD
       A.E. Ogwell, Kenya Ministry of Health


6:30pm Participant dinner


Tuesday, Jan 29

Panel 6  - Economists on prizes

          Chair: Rishab Ghosh, UNU-MERIT

          Dominique Foray, Ecole Polytechnique F=E9d=E9rale de Lausanne

          Ove Grandstrand, Chalmers University of Technology, Sweden
          Bart Verspagen, Eindhoven University of Technology

Break

Panel 7   Sustainable financing for prizes

        Chair: Ahmed Latif, ICTSD

        Michelle Childs, KEI, A prize mechanism for UNITAID/Global Fund
        Peter Brown, SecurePharma, possible role of the International
Finance Facility (IFF) in providing credible and sustainable sources of
funding for innovation prizes for neglected diseases
        Nicoletta Dentico, DNDi, Transaction based funding mechanisms
for public goods
        Speaker(s) TBA, Funding of prizes linked to shares of GDP or
health care budgets

Lunch

Panel 8      The management of prizes

        Chair: Oliver Moldenhauer, MSF

        Amy Kapczynski, Berkeley, Legal Issues
        Ron Marchant, former Chief Executive of the UK Intellectual
Property Office
        Rainer Sauerborn, University of Heidelberg, Germany
        James Love, KEI  Issues in valuation of prizes
        Kalipso Chalkidou, UK NICE, Valuing Prizes and Reimbursements,
how different?


Break

Panel 9    Conclusions and Next Steps

         Chair:  Luc Soete, UNU-MERIT

         Sisule Musungu, Yale
         Ahmed Latif, ICTSD
         A.E. Ogwell, Kenya Ministry of Health
         Greg Perry, European Generic Medicines Association
         Ove Grandstrand, Chalmers University of Technology, Sweden
         Rishab Ghosh, UNU-MERIT
         James Love, KEI